About Turmeric Acquisition Corp
It operates as a B2B and Venture Capital. Turmeric Acquisition Corp has completed 1 acquisition, including Reunion Neuroscience. Turmeric Acquisition Corp offers products and services including Orna Therapeutics, Aktis Oncology, ElevateBio, and NextPoint Therapeutics.
- SectorsHealthcare
- Email••••••••
- Website mpmcapital.com/companies/turmeric-acquisition-corp
- Social LinkedIn X
- Legal Name Mpm Bioimpact Llc
- Investments & Acquisitions
Products & Services of Turmeric Acquisition Corp
Turmeric Acquisition Corp offers a comprehensive portfolio of products and services, including Orna Therapeutics, Aktis Oncology, ElevateBio, and NextPoint Therapeutics.
Develops circular RNA medicines for autoimmune and oncology treatments.
Advances alpha radio-pharmaceuticals for solid tumor therapies.
Provides cell, gene, and RNA therapy manufacturing solutions.
Targets new axes in cancer biology for precision therapies.
People of Turmeric Acquisition Corp
35 people are tracked at Turmeric Acquisition Corp (25 in leadership, 5 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Ansbert Gadicke | Co-Founder & Co-Managing Director | Leadership |
Pankaj Bhargava | Executive Partner | Leadership |
Briggs W. Morrison | Executive Partner | Leadership |
Luke Evnin | Co-Founder & Co-Managing Director | Leadership |
Matthew Roden | Executive Partner | Leadership |
Frank Neumann | Entrepreneur Partner | Leadership |
Christian Desmarteaux | Director of Marketing & Investor Relations | Leadership |
Thomas M. Barnes | Executive Partner & Entrepreneur | Leadership |
Elizabeth Stoner | Executive Partner & Entrepreneur | Leadership |
Patrick A. Baeuerle | Executive Partner & Entrepreneur | Leadership |
Detlev Biniszkiewicz | Managing Director | Leadership |
Florencia Segal | Partner | Leadership |
Brendan Furey | Chief Compliance Officer | Leadership |
Rami Rahal | Partner | Leadership |
Christopher Wolf | Chief Financial Officer | Leadership |
Joseph Bolen | Partner | Leadership |
Dave Stack | Managing Director | Leadership |
Todd Foley | Managing Director | Leadership |
Vaughn Kailian | Managing Director | Leadership |
Christiana Bardon M.d. | Co Managing Partner | Leadership |
15 more people are available in the full profile.
Complete people profiles for Turmeric Acquisition Corp
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Turmeric Acquisition Corp
Turmeric Acquisition Corp has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Reunion Neuroscience.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapeutics for mental health conditions are developed using serotonergic psychedelics. | reunionneuro.com | Toronto, Canada | 2022 | Jun 2023 | $13.1M |
Complete acquisition details for Turmeric Acquisition Corp
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Web traffic of Turmeric Acquisition Corp
Websites that share an audience with Turmeric Acquisition Corp (mpmcapital.com).
Websites whose visitors overlap most with Turmeric Acquisition Corp. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cmgi.com | 100% | – | – | View details | |
| orbimed.com | 98% | 30.6K | #933,486 | View details | |
| solcap.com | 93% | – | – | View details | |
| centurycap.com | 85% | – | – | View details | |
| harbourvest.com | 83% | 81.1K | #491,091 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Turmeric Acquisition Corp
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Turmeric Acquisition Corp
Complete news archive for Turmeric Acquisition Corp
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Turmeric Acquisition Corp
10 companies that operate in the same segment as Turmeric Acquisition Corp (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Turmeric Acquisition Corp
MPM BioImpact is a venture capital firm based in Boston that creates and invests in biotech companies focused on innovative technologies for drug development. They support areas like RNA medicines, radiopharmaceuticals, and cancer therapies by partnering with scientists and entrepreneurs. Through their investments, they aim to transform patient outcomes by funding both private and public companies.
Turmeric Acquisition Corp offers Orna Therapeutics, Aktis Oncology, ElevateBio, and NextPoint Therapeutics.
Turmeric Acquisition Corp has made 1 acquisition, including Reunion Neuroscience.
Turmeric Acquisition Corp operates through Mpm Bioimpact Llc.